Dennis KAPPEI
Our research group is interested in how telomere-driven genomic instability contributes to carcinogenesis. For this purpose, we leverage our strength in quantitative mass spectrometry analysis to both identify novel, direct telomere-binding proteins as well as to study changes in telomeric chromatin composition upon genetic manipulation. For the latter we have established workflows for label-free quantitative proteomics analysis in combination with chromatin immunoprecipitation (qChIP-MS) and extended this work to locus-specific purification workflows. Since many telomeric proteins moonlight as transcription factors, we further study the mechanism and functional impact of their gene regulatory roles both as a feedback loop with telomeres as well as to carefully dissect separation of function.
We further contribute our expertise in mass spectrometry analysis to the CSI and larger Singapore research community via the Quantitative Proteomics Core with a particular focus on clinical proteomics.
dennis.kappei[at]nus.edu.sg
Principal Investigator, Cancer Science Institute of Singapore, NUS
Assistant Professor, Department of Biochemistry, Yong Loo Lin School of Medicine, NUS
2024 - 2027 | EMBO Global Investigator Network (EMBO GIN) |
2013 | Georg Helm Prize, TU Dresden |
2005 - 2007 | Rotary Foundation Multi-Year Ambassadorial Scholarship |
2003 - 2007 | German National Merit Foundation Undergraduate Fellowship |
Telomeres are nucleoprotein structures at the end of linear chromosomes and solve two fundamental challenges of linear genome organization: The incomplete replication of linear DNA ultimately leads to cellular senescence when one or a few telomeres reach a critically short length, a process termed ‘end replication problem’. Each cancer cell would also ultimately share this fate. However, they circumvent telomere shortening by one of two mechanisms: 85% of all tumors reactivate the expression of telomerase while the other 15 % use a recombination-based mechanism, termed Alternative Lengthening of Telomeres (ALT). In addition, the ‘end protection problem’ essentially leads to telomere-telomere fusions if telomeres are not efficiently hidden from recognition as double-stranded breaks. Both telomere shortening and deprotection may result in chromosomal fusions and subsequently breakage-fusion-bridge cycles that lead to telomere-driven genome instability. Through our expertise in quantitative proteomics we have identified several proteins that directly bind to telomeres and we are now studying how they contribute to telomere homeostasis and impact carcinogenesis.
Using a DNA pull-down assay based on in vitro reconstitution combined with quantitative mass spectrometry, we identified HOT1 as a direct telomere binding protein. In vivo, HOT1 acts as a dynamic telomere-binding protein with increased telomere association during active telomere elongation. In agreement with this, subsequent experiments have shown that HOT1 likely contributes to telomerase recruitment. We have since extended this approach and systematically investigated telomere-binding proteins in 16 vertebrate species, creating a phylointeractomics map of telomeres from zebrafish to human. Beyond known telomere-binding proteins, our screen discovered a series of zinc finger proteins, ZBTB48, ZNF524 and ZBTB10, that directly bind to telomeric DNA (and its variant sequences) through a conserved zinc finger motif. These proteins contribute to telomere homeostasis, e.g. ZBTB48 limits telomere elongation while ZNF524 supports telomere integrity. In addition, these proteins moonlight in non-telomeric functions, e.g. ZBTB48 also acts as a transcriptional activator by regulating chromatin accessibility at target promoters. We are now expanding our mechanistic understanding of these factors and their impact on chromatin organization, among others through in-house developed approaches interrogating chromatin compositions by quantitative mass spectrometry.
*These authors contributed equally to this work
#Shared correspondence